New Humana Partnership Aims to Improve Preauthorization
Published:
October 30, 2020
New Humana partnership aims to improve preauthorization in 12 states
Humana is partnering with digital healthcare company Cohere Health to change the prior authorization process for musculoskeletal treatment in 12 states.
Musculoskeletal treatment affects bones, muscles, ligaments, tendons and nerves. Beginning Jan. 1, Humana will use Cohere’s technology to grant authorizations from initial diagnosis to treatment plan selection, or across the entire episode of care, for musculoskeletal conditions.
About 2 million members and 3,500-plus physicians will have access to the process.
The new musculoskeletal prior authorization process will be deployed in Alabama, Georgia, Indiana, Kentucky, Michigan, North Carolina, Ohio, Pennsylvania, South Carolina, Tennessee, Virginia and West Virginia.
Written by
Cohere
Health
Cohere Health’s clinical intelligence platform and agentic AI-powered solutions connect health plans’ strategic goals and providers’ needs, optimizing the speed, cost, and quality of care. With an enterprise approach that streamlines payer-provider decision-making across the care continuum–including policy, prior authorization, payment accuracy, and more–the company improves collaboration and reduces burden, resulting in up to 8x ROI and 94% provider satisfaction. Cohere Health is recognized on TIME’s World’s Top HealthTech Companies 2025 list, on the 2025 Inc. 5000 list, and by numerous industry analysts.
Stay ahead with expert insights on transforming utilization management and payment integrity—delivered straight to your inbox.
